Padagis Nystatin Cream
Nystatin Cream USP is subpotent, with low assay results from stability testing.
Nystatin Cream USP is subpotent, with low assay results from stability testing.
Fexofenadine Hydrochloride Tablets failed impurities and degradation specifications.
Apheresis Platelets, Leukocytes Reduced, Irradiated were labeled as leukocytes reduced but were not tested to verify white blood cell count.
Methohexital Sodium failed impurities and degradation specifications.
Medline Remedy Specialized Silicone Cream has formaldehyde levels exceeding specification.
Methohexital Sodium for Injection failed impurities and degradation specifications.
Surgical dressing manufactured out of specification (greater thickness).
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
3 productsThe Zeiss Intrabeam Spherical Applicator 1.5 cm failed to meet manufacturing specifications.
Pilling Wecksorb Neurosponges and Neurosponge Strips may have out-of-specification levels of endotoxins.
Medline urethral catheters and kits may have surface irregularities or connector issues.
30 productsChlorthalidone Tablets fail dissolution specifications.
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
KERR INSTA-CHAR activated charcoal products did not meet the OTC Monograph.
4 productsNiacin extended-release tablets failed dissolution specifications during stability testing.
Minocycline Hydrochloride Extended-Release Tablets failed dissolution specifications during testing.
Epinephrine Injection failed impurities and degradations specifications.
Niacin Extended-release Tablets failed dissolution specifications during stability testing.
This herbal supplement with vitamins does not meet label claim for Vitamin E.
Amlodipine and Olmesartan Medoxomil Tablets have failed dissolution specifications, with olmesartan medoxomil content below specifications.
Pred Mild ophthalmic suspension failed stability specifications.
The patch failed impurity tests due to elevated oxidative-related impurities.
Nitrile exam gloves failed to meet chemical permeation performance specifications.
Busulfan Injection failed impurities and degradation specifications.
The CerebroFlo EVD Catheter has an out-of-specification endotoxin result that did not meet acceptance criteria.
Enalapril Maleate Tablets failed impurities/degradation specifications due to an out-of-specification result in organic impurities test.
Lidocaine Wound Gel failed pH specifications.
Medline Neuro Sponges may have higher-than-expected endotoxin levels.
31 productsThis recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Oxoid Agglutinating Sera, Salmonella 9-0 is not performing to IFU criteria, showing cross reactions.
Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram failed capsule specifications for loss on drying of capsule shells.
Claravis (isotretinoin capsule, USP), 10 mg, failed impurities/degradation specifications for specific impurity Tretinoin.
3 productsBlemish Spot Treatment failed stability specifications.
Cytal Wound Matrix and Cytal Burn Matrix have an increased rate of out-of-specification endotoxin results.
5 productsThe React Health PHOENIX 5L Oxygen Concentrator was distributed without meeting internal quality specifications.
Memantine Hydrochloride Extended-Release Capsules failed dissolution specifications.
Xanax XR extended-release tablets failed dissolution specifications.
Bromfenac Ophthalmic Solution 0.07% failed impurities and degradation specifications at the 20th month stability testing.
TraMADol Hydrochloride Tablets contain an impurity that failed specifications.
Meclizine Hydrochloride Tablets failed tablet specifications.
Drill plates manufactured out of specification can result in a bone cut in excess 00800"(2.8448mm).
2 productsThe Gelatin Capsule Pack failed tablet or capsule specifications.
Dexamethasone Sodium Phosphate Injection failed impurity specifications.
Icosapent Ethyl Capsules have red dots inside and melted capsules due to oxidized active ingredient.
BioCox 60 failed to meet stability specification requirements for assay.
Temozolomide Capsules failed impurities and degradation specifications during stability testing.
Stability Data Does Not Support Expiry Date.
3 productsAmnesteem (Isotretinoin) Capsules, USP 40 mg failed dissolution specifications.
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
2 products